Polymorphisms of IL-1β gene in Japanese patients with Sjogren's syndrome and systemic lupus erythematosus

被引:0
|
作者
Muraki, Y
Tsutsumi, A
Takahashi, R
Suzuki, E
Hayashi, T
Chino, Y
Goto, D
Matsumoto, I
Murata, H
Noguchi, E
Sumida, T
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Div Rheumatol, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Inst Basic Med Sci, Dept Med Genet, Tsukuba, Ibaraki 3058575, Japan
关键词
interleukin; 1; beta; gene polymorphism; sjogren's syndrome; systemic lupus erythematosus;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Interleukin (IL)-1beta is a proinflammatory cytokine involved in various immune responses. Five polymorphisms in the IL-1beta gene have been described, and relationships between these polymorphisms and some autoimmune diseases have been reported. Evidence suggests that IL-1beta may be involved in the destruction of salivary and lacrimal glands in Sjogren's syndrome (SS). We evaluated the significance of IL-1beta gene polymorphisms in SS. Methods. Blood samples were taken from 101 patients with SS, 103 patients with systemic lupus erythematosus (SLE, excluding those with secondary SS), and 106 healthy volunteers. Each polymorphism of the IL-1beta gene was analyzed by polymerase chain reaction (PCR) amplification of the polymorphic site, followed by site-specific restriction digestion. Genotype frequencies of each polymorphism in SS patients were compared with those of the controls and SLE patients, and differences between primary and secondary SS patients were also compared. Results. Genotypes CC, TT, and AA in positions -511, -31, and 3877, respectively, were significantly less frequent in SS patients than controls or patients with SLE. No significant differences were found in genotype frequencies of any of the polymorphisms between patients with, primary SS and secondary SS. Conclusion. IL-1beta gene polymorphisms may affect susceptibility to SS, but not SLE.
引用
收藏
页码:720 / 725
页数:6
相关论文
共 50 条
  • [41] Secondary Sjogren's Syndrome in Systemic Lupus Erythematosus Defines a Distinct Disease Subset
    Baer, Alan N.
    Maynard, Janet W.
    Shaikh, Fasil
    Magder, Laurence S.
    Petri, Michelle
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1143 - 1149
  • [42] An update on the role of type I interferons in systemic lupus erythematosus and Sjogren's syndrome
    Thorlacius, Gudny Ella
    Wahren-Herlenius, Marie
    Ronnblom, Lars
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (05) : 471 - 481
  • [43] Secreted autoantibody repertoires in Sjogren's syndrome and systemic lupus erythematosus: A proteomic approach
    Al Kindi, Mahmood A.
    Colella, Alex D.
    Chataway, Tim K.
    Jackson, Michael W.
    Wang, Jing J.
    Gordon, Tom P.
    AUTOIMMUNITY REVIEWS, 2016, 15 (04) : 405 - 410
  • [44] HLA DR-DQ haplotypes and genotypes in patients with systemic lupus erythematosus with co-existing Sjogren's syndrome, systemic lupus erythematosus without Sjogren's syndrome and primary Sjogren's syndrome: clinical and laboratory associations
    Ch Georgopoulou
    E Zintzaras
    M Papadimitropoulos
    M Spyropoulou
    A Stavropoulou
    HM Moutsopoulos
    MN Manoussakis
    Arthritis Research & Therapy, 7
  • [45] Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome
    Coca, Andreea
    Sanz, Inaki
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (05) : 451 - 456
  • [46] The association between hydroxychloroquine use and future development of systemic lupus erythematosus in patients with primary Sjogren's syndrome
    Hsu, Bo-Chueh
    Chen, Yi-Hsing
    Lin, Ching-Heng
    Tang, Kuo-Tung
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (12) : 1424 - 1430
  • [47] Association of OSMR Gene Polymorphisms with Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients
    Lin, Yuan-Zhao
    Li, Ruei-Nian
    Lin, Chia-Hui
    Ou, Tsan-Teng
    Wu, Cheng-Chin
    Tsai, Wen-Chan
    Liu, Hong-Wen
    Yen, Jeng-Hsien
    AUTOIMMUNITY, 2014, 47 (01) : 23 - 26
  • [48] Variability of fatigue during the day in patients with primary Sjogren's syndrome, systemic lupus erythematosus, and rheumatoid arthritis
    van Oers, M. L.
    Bossema, E. R.
    Thoolen, B. J.
    Hartkamp, A.
    Dekkers, J. C.
    Godaert, G. L. R.
    Kruize, A. A.
    Derksen, R. H. W. M.
    Bijlsma, J. W. J.
    Geenen, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : 715 - 721
  • [49] Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjogren's syndrome and systemic lupus erythematosus associated with Sjogren's syndrome
    Hernandez-Molina, G.
    Soto-Abraham, V
    Zamora-Legoff, V
    Furuzawa-Carballeda, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (06) : S49 - S56
  • [50] Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjogren's syndrome and systemic sclerosis
    Hebbar, M
    Jeannin, P
    Magistrelli, G
    Hatron, PY
    Hachulla, E
    Devulder, B
    Bonnefoy, JY
    Delneste, Y
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (02) : 388 - 392